MRI measurement of hepatic magnetic susceptibility - Phantom validation and normal subject studies

被引:20
作者
Chu, ZL
Cohen, AR
Muthupillai, R
Chung, T
Wang, ZYJ
机构
[1] Texas Childrens Hosp, Edward B Singleton Dept Diagnost Imaging, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA
[3] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[4] Philips Med Syst, Cleveland, OH USA
关键词
magnetic susceptibility; magnetic resonance imaging; liver; quantification; iron;
D O I
10.1002/mrm.20305
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A magnetic resonance (MR) imaging method with the potential for assessing hepatic iron overload from measurements of hepatic magnetic susceptibility in vivo is described. Using the blood in the portal and hepatic veins as an internal reference, this technique uses the orientation dependence of signal phase to measure the susceptibility of the liver parenchyma. Computer simulations were done to investigate the requirements on spatial resolution and contrast ratio between the vessels and the background liver tissue for data acquisition. Validation studies were conducted using tube-embedded gel phantoms doped with iron-dextran from 0 to 10 mg Fe/mL to mimic healthy and iron-overloaded livers. The phantom measurements were conducted without motion and flow, under respiration-like oscillatory motion, and with flow. Studies on six normal human subjects demonstrated excellent reproducibility and precision. All images were collected at 11.5 T using a 3D T-1-weighted turbo field echo sequence for inflow MR angiographies with full flow compensation and capable of cardiac synchronization, navigator gating, and motion correction. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:1318 / 1327
页数:10
相关论文
共 36 条
[1]   Contrast-agent phase effects: An experimental system for analysis of susceptibility, concentration, and bolus input function kinetics [J].
Akbudak, E ;
Norberg, RE ;
Conturo, TE .
MAGNETIC RESONANCE IN MEDICINE, 1997, 38 (06) :990-1002
[2]   UNEVEN HEPATIC IRON AND PHOSPHORUS DISTRIBUTION IN BETA-THALASSEMIA [J].
AMBU, R ;
CRISPONI, G ;
SCIOT, R ;
VANEYKEN, P ;
PARODO, G ;
IANNELLI, S ;
MARONGIU, F ;
SILVAGNI, R ;
NURCHI, V ;
COSTA, V ;
FAA, G ;
DESMET, VJ .
JOURNAL OF HEPATOLOGY, 1995, 23 (05) :544-549
[3]   Hepatic iron concentration and total body iron stores in thalassemia major. [J].
Angelucci, E ;
Brittenham, GM ;
McLaren, CE ;
Ripalti, M ;
Baronciani, D ;
Giardini, C ;
Galimberti, M ;
Polchi, P ;
Lucarelli, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (05) :327-331
[4]   VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1986, 6 (01) :24-29
[5]  
BAUMAN JH, 1967, J LAB CLIN MED, V70, P246
[6]   Magnetic resonance imaging for the determination of magnetic susceptibility of materials [J].
Beuf, O ;
Briguet, A ;
Lissac, M ;
Davis, R .
JOURNAL OF MAGNETIC RESONANCE SERIES B, 1996, 112 (02) :111-118
[7]   Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[8]   Noninvasive measurement of iron: report of an NIDDK workshop [J].
Brittenham, GM ;
Badman, DG .
BLOOD, 2003, 101 (01) :15-19
[9]   MAGNETIC-SUSCEPTIBILITY MEASUREMENT OF HUMAN IRON STORES [J].
BRITTENHAM, GM ;
FARRELL, DE ;
HARRIS, JW ;
FELDMAN, ES ;
DANISH, EH ;
MUIR, WA ;
TRIPP, JH ;
BELLON, EM .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27) :1671-1675
[10]   HEPATIC IRON STORES AND PLASMA FERRITIN CONCENTRATION IN PATIENTS WITH SICKLE-CELL-ANEMIA AND THALASSEMIA MAJOR [J].
BRITTENHAM, GM ;
COHEN, AR ;
MCLAREN, CE ;
MARTIN, MB ;
GRIFFITH, PM ;
NIENHUIS, AW ;
YOUNG, NS ;
ALLEN, CJ ;
FARRELL, DE ;
HARRIS, JW .
AMERICAN JOURNAL OF HEMATOLOGY, 1993, 42 (01) :81-85